tripeptide tyroservatide

Known as: YSV tripeptide 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

2006-2017
012320062017

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
Nanoscale drug delivery systems (DDSs) are generally considered to be an effective alternative to small molecular… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2008
2008
OBJECTIVE To investigate the inhibitory effect of tyroservatide (YSV) on growth of hepatocellular carcinoma cells. METHODS In… (More)
Is this relevant?
2007
2007
The tripeptide tyroservatide (tyrosyl-seryl-valine, pTyr-Ser-Val-NH2) has been shown to have antitumor effects on experimental… (More)
Is this relevant?
2006
2006
The tripeptide, tyroservatide (YSV), has been previously shown to have antitumor effects through unknown mechanism. In the… (More)
Is this relevant?
2006
2006
OBJECTIVES The tripeptide tyroservatide (tyrosyl-seryl-valine, p-Tyr-Ser-Val-NH(2), YSV) has been shown to have anti-tumor… (More)
Is this relevant?
2006
2006
Tyroservatide (YSV) is a bioactive tripeptide of tyrosyl-seryl-valine. In this study, we studied the effects of YSV on human… (More)
Is this relevant?